German RepRap 100256 データシート

ページ / 10
 
 
Product name:
Ingeo
™ biopolymer
___________________________________________________________ 
All ingredients in quantities > 1.0% (0.1% for carcinogens) that are potentially hazardous 
per OSHA definitions. 
 
Other Standards:
This material can generate Particulates Not Otherwise 
Classifiable (PNOC). The Occupational Safety and Health 
Administration (OSHA) PEL/TWA for PNOC is 15 mg/m
3
 for total 
dust and 5 mg/m
3
 for the respirable fraction. The American 
Conference of Governmental Industrial Hygienists (ACGIH) 
TLV/TWA for PNOC is 10 mg/m
3
 for inhalable particulates and 3 
mg/m
3
 for respirable particulates.
 
 
4. FIRST AID MEASURES
  
 
Emergency telephone numbers (24 hours a day):
• (Medical Information) (651) 632-9273 
• (Tranportation Information) CHEMTREC: 800-424-9300 (in the United States) 
• (Transportation Information) CHEMTREC: (703) 527-3887 (outside the United States)
 
Eye contact: 
Rinse immediately with plenty of water, also under the eyelids, for at least 
15 minutes. Call a physician immediately.
 
Skin contact: 
Rinse immediately with plenty of water for at least 15 minutes. If skin 
irritation persists, call a physician. Cool skin rapidly with cold water after contact 
with hot polymer.
 
Inhalation: 
Move to fresh air. Call a physician immediately.
 
Ingestion: 
Drink water as a precaution. Never give anything by mouth to an unconscious 
person. Do not induce vomiting without medical advice. Call a physician immediately.
 
Notes to physician: 
Treat symptomatically.
 
5.   FIRE FIGHTING MEASURES
 
___________________________________________________________ 
The Information Herein Is Given In Good Faith, But No Warranty, Express Or Implied, Is Made.  
Consult the Company for Further Information. 
Ingeo and the Ingeo logo are trademarks or registered trademarks of NatureWorks in the USA and other 
countries. 
NOTICE REGARDING MEDICAL APPLICATION RESTRICTIONS: The company does not recommend any of its 
products, including samples, for use: (A) in any application which is intended for any internal 
contact with human body fluids or body tissues (B) as a critical component in any medical device 
that supports or sustains human life; and (C) specifically pregnant women or in any applications 
designed specifically to promote or interfere with human reproduction. 
 
Page  3 of 10 
Revision Number:  13 
Revision date:
04/01/2010 
Print date:
09/16/2010 
Product code:
4